MMP2 and myeloid sarcoma: Our present study demonstrated that the BBB function was restored after adding GM6001 or a neutralizing anti-VEGF antibody to the sera from relapsing MS patients, indicating that MMP-2/9 and VEGF are the key molecules responsible for the disruption of the BBB in the relapsing MS patients.